Evergen (Formerly Cook Biotech)

Evergen is a prominent Contract Development and Manufacturing Organization (CDMO) that specializes in regenerative biomaterial solutions for the medical industry. Originally established as Cook Biotech in 1995, the company has a rich history of innovation in regenerative medicine, focusing on biologic tissue grafts that utilize extracellular matrix (ECM) technology. Their products are widely used in soft tissue repair treatments, including applications for fistulas, hernias, and wounds. The company provides a full range of services throughout the product lifecycle, including design, development, regulatory support, manufacturing, and supply chain management. Evergen collaborates with medical companies to expedite the development and commercialization of solutions that enhance patient outcomes. Their product portfolio features allograft and xenograft biomaterials, particularly leveraging the clinically effective porcine small intestinal submucosa (SIS) platform. With a commitment to values such as accountability, customer focus, and inclusivity, Evergen serves a diverse clientele in the regenerative medicine sector, including medical device companies and healthcare providers. Their expertise and comprehensive services aim to improve healing and outcomes in soft tissue repair.

• Employees 140
• Founded 1995
• Annual Revenue $37700000